BiondVax Pharmaceuticals Ltd.
BVXV · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,796 | -$39,978 | -$4,455 | -$109,194 |
| Dep. & Amort. | $562 | $2,415 | $2,436 | $1,645 |
| Deferred Tax | $0 | -$33 | -$37 | -$122 |
| Stock-Based Comp. | $1,602 | $8,904 | $9,472 | $3,684 |
| Change in WC | $271 | $5,178 | -$92,735 | $11,027 |
| Other Non-Cash | -$3,904 | -$970 | $12,780 | $15,902 |
| Operating Cash Flow | -$7,265 | -$24,484 | -$72,539 | -$77,058 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$836 | -$430 | -$6,132 | -$7,429 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $69 | $197 | $230 |
| Investing Cash Flow | -$836 | -$361 | -$5,935 | -$7,199 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $932 | $69,003 | $0 | $70,270 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,776 | $67,783 | $13,716 | $85,214 |
| Financing Cash Flow | $6,776 | $67,783 | $13,716 | $85,214 |
| Forex Effect | -$1,977 | $1,677 | $1,712 | -$4,373 |
| Net Chg. in Cash | -$3,302 | $44,615 | -$63,046 | -$3,416 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,517 | $9,421 | $72,467 | $75,883 |
| End Cash | $14,215 | $54,036 | $9,421 | $72,467 |
| Free Cash Flow | -$8,101 | -$24,914 | -$78,671 | -$84,487 |